Abstract
In the last few decades, mesenchymal stem cells (MSCs)-based regenerative therapies in clinical applications have gradually become a hot topic due to their long-term self-renewal and multilineage differentiation ability. In this scenario, placenta (p) has been considered as a good source of MSCs. As a tissue of fetal origin with abundant number of stem cells compared to other sources, their non-invasive acquisition, strong immunosuppression, and lack of ethical concerns make placenta an indispensable source of MSC in stem cell research and therapy. The mesenchymal stem cells were derived from human term placenta (p-MSCs) in xenofree condition using platelet lysate (PL) as a suitable alternative to fetal bovine serum (FBS). Upon isolation, p-MSCs showed plastic adherence with spindle-shaped, fibroblast-like morphology under microscope. p-MSCs flourished well in PL-containing media. Immunophenotyping showed classical MSC markers (> 90%) and lack expression of hematopoietic and HLA-DR (< 1%). Surprisingly, differentiation study showed differentiation of p-MSCs to mature adipocytes in both induced cells and control (spontaneous differentiation), as observed via oil red staining. This is in line with gene expression data where both control and induced cells were positive for visfatin and leptin. Thus, we propose that p-MSCs can be used for clinical applications in the treatment of various chronic and degenerative diseases.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Amirkhani MA, Mohseni R, Soleimani M et al (2016) A rapid sonication based method for preparation of stromal vascular fraction and mesenchymal stem cells from fat tissue. BioImpacts 6:99–104. https://doi.org/10.15171/bi.2016.14
Antoninus AA, Widowati W, Wijaya L et al (2015) Human platelet lysate enhances the proliferation of Wharton’s jelly-derived mesenchymal stem cells. Biomark Genomic Med 7:87–97. https://doi.org/10.1016/j.bgm.2015.06.001
Baker N, Boyette LB, Tuan RS (2015) Characterization of bone marrow-derived mesenchymal stem cells in aging. Bone 70:37–47. https://doi.org/10.1016/j.bone.2014.10.014
Becherucci V, Piccini L, Casamassima S et al (2018) Human platelet lysate in mesenchymal stromal cell expansion according to a GMP grade protocol: a cell factory experience. Stem Cell Res Ther 9:1–10. https://doi.org/10.1186/s13287-018-0863-8
Brown C, McKee C, Bakshi S et al (2019) Mesenchymal stem cells: cell therapy and regeneration potential. J Tissue Eng Regen Med 13:1738–1755. https://doi.org/10.1002/term.2914
Čamernik K, Mihelič A, Mihalič R et al (2019) Skeletal-muscle-derived mesenchymal stem/stromal cells from patients with osteoarthritis show superior biological properties compared to bone-derived cells. Stem Cell Res. https://doi.org/10.1016/j.scr.2019.101465
Caplan AI (2015) Adult mesenchymal stem cells: when, where, and how. Stem Cells Int 2015:1. https://doi.org/10.1155/2015/628767
Chen Y, Yu Q, Hu Y, Shi Y (2019) Current research and use of mesenchymal stem cells in the therapy of autoimmune diseases. Curr Stem Cell Res Ther 14:579–582
Chen C, Lou Y, Li XY et al (2020) Mapping current research and identifying hotspots on mesenchymal stem cells in cardiovascular disease. Stem Cell Res Ther 11:1–16. https://doi.org/10.1186/s13287-020-02009-7
Consulting CG, Diamond B, Lake S (2015) Standards, policies, protocols, and regulations for cell-based therapies concise review: making and using clinically compliant pluripotent stem cell lines. Bone 74:381–388
da Silva ML, Caplan AI, Nardi NB (2008) In search of the in vivo identity of mesenchymal stem cells. Stem Cells 26:2287–2299. https://doi.org/10.1634/stemcells.2007-1122
De Castro LL, Xisto DG, Kitoko JZ et al (2017) Human adipose tissue mesenchymal stromal cells and their extracellular vesicles act differentially on lung mechanics and inflammation in experimental allergic asthma. Stem Cell Res Ther 8:1–12. https://doi.org/10.1186/s13287-017-0600-8
Ding DC, Chang YH, Shyu WC, Lin SZ (2015) Human umbilical cord mesenchymal stem cells: a new era for stem cell therapy. Cell Transplant 24:339–347. https://doi.org/10.3727/096368915X686841
Dominici M, Le Blanc K, Mueller I et al (2006) Minimal criteria for defining multipotent mesenchymal stromal cells. The international society for cellular therapy position statement. Cytotherapy 8:315–317. https://doi.org/10.1080/14653240600855905
Fan XL, Zhang Z, Ma CY, Fu QL (2019) Mesenchymal stem cells for inflammatory airway disorders: promises and challenges. Biosci Rep 39:1–13. https://doi.org/10.1042/BSR20182160
Fani N, Ziadlou R, Shahhoseini M, Baghaban Eslaminejad M (2016) Comparative epigenetic influence of autologous versus fetal bovine serum on mesenchymal stem cells through in vitro osteogenic and adipogenic differentiation. Exp Cell Res 344:176–182. https://doi.org/10.1016/j.yexcr.2015.10.009
Friedenstein AJ, Chailakhjan RK, Lalykina KS (1970) The development of fibroblast colonies in monolayer cultures of guinea-pig bone marrow and spleen cells. Cell Prolif 3:393–403
Gao F, Chiu SM, Motan DAL et al (2016) Mesenchymal stem cells and immunomodulation: current status and future prospects. Cell Death Dis. https://doi.org/10.1038/cddis.2015.327
Ghorbani A, Jalali SA, Varedi M (2014) Isolation of adipose tissue mesenchymal stem cells without tissue destruction: a non-enzymatic method. Tissue Cell 46:54–58. https://doi.org/10.1016/j.tice.2013.11.002
Hmadcha A, Martin-Montalvo A, Gauthier BR et al (2020) Therapeutic potential of mesenchymal stem cells for cancer therapy. Front Bioeng Biotechnol 8:1–13. https://doi.org/10.3389/fbioe.2020.00043
Horwitz EM, Le Blanc K, Dominici M et al (2005) Clarification of the nomenclature for MSC: the international society for cellular therapy position statement. Cytotherapy 7:393–395. https://doi.org/10.1080/14653240500319234
Jiang W, Xu J (2020) Immune modulation by mesenchymal stem cells. Cell Prolif. https://doi.org/10.1111/cpr.12712
Kandoi S, Praveen Kumar L, Patra B et al (2018) Evaluation of platelet lysate as a substitute for FBS in explant and enzymatic isolation methods of human umbilical cord MSCs. Sci Rep 8:1–12. https://doi.org/10.1038/s41598-018-30772-4
Klimczak A, Kozlowska U, Kurpisz M (2018) Muscle stem/progenitor cells and mesenchymal stem cells of bone marrow origin for skeletal muscle regeneration in muscular dystrophies. Arch Immunol Ther Exp (warsz) 66:341–354. https://doi.org/10.1007/s00005-018-0509-7
Klimczak A, Kozlowska U (2016) Mesenchymal stromal cells and tissue-specific progenitor cells: their role in tissue homeostasis. Stem Cells Int. https://doi.org/10.1155/2016/4285215
Komaki M, Numata Y, Morioka C et al (2017) Exosomes of human placenta-derived mesenchymal stem cells stimulate angiogenesis. Stem Cell Res Ther 8:1–12. https://doi.org/10.1186/s13287-017-0660-9
Li N, Hua J (2017) Interactions between mesenchymal stem cells and the immune system. Cell Mol Life Sci 74:2345–2360. https://doi.org/10.1007/s00018-017-2473-5
Liao Y, Ivanova L, Plumer T et al (2016) Potential use of human placenta derived stem cell (HPDSCs) as a novel stem cell source for the treatment of recessive dystrophic epidermolysis bullosa (RDEB). Biol Blood Marrow Transpl 22:S422–S423. https://doi.org/10.1016/j.bbmt.2015.11.964
Liu Y, Zhang Z, Zhang C et al (2016) Adipose-derived stem cells undergo spontaneous osteogenic differentiation in vitro when passaged serially or seeded at low density. Biotech Histochem 91:369–376. https://doi.org/10.1080/10520295.2016.1175026
Lukomska B, Stanaszek L, Zuba-Surma E et al (2019) Challenges and controversies in human mesenchymal stem cell therapy. Stem Cells Int. https://doi.org/10.1155/2019/9628536
Macrin D, Joseph JP, Pillai AA, Devi A (2017) Eminent sources of adult mesenchymal stem cells and their therapeutic imminence. Stem Cell Rev Rep 13:741–756. https://doi.org/10.1007/s12015-017-9759-8
Maria ATJ, Maumus M, Le Quellec A et al (2017) Adipose-derived mesenchymal stem cells in autoimmune disorders: state of the art and perspectives for systemic sclerosis. Clin Rev Allergy Immunol 52:234–259. https://doi.org/10.1007/s12016-016-8552-9
Mattar P, Bieback K (2015) Comparing the immunomodulatory properties of bone marrow, adipose tissue, and birth-associated tissue mesenchymal stromal cells. Front Immunol 6:1–8. https://doi.org/10.3389/fimmu.2015.00560
Miettinen S, Sarkanen J-R, Ashammakhi N (2008) Adipose tissue and adipocyte differentiation: molecular and cellular aspects and tissue engineering applications prognostications and cancer view project TEKES funded multifunctional biomaterials view project
Moreira A, Kahlenberg S, Hornsby P (2017) Therapeutic potential of mesenchymal stem cells for diabetes. J Mol Endocrinol 59:R109–R120. https://doi.org/10.1530/JME-17-0117
Nagamura-Inoue T (2014) Umbilical cord-derived mesenchymal stem cells: their advantages and potential clinical utility. World J Stem Cells 6:195. https://doi.org/10.4252/wjsc.v6.i2.195
Nanjwade BK, Sudulaguntla A, Gurung S, Tamang JK (2016) A review: stem cells and classification of stem cells based on their origin. Sudulaguntla Al World J Pharm Pharm Sci 5:534. https://doi.org/10.20959/wjpps201611-7994
Naruse K, Urabe K, Mukaida T et al (2004) Spontaneous differentiation of mesenchymal stem cells obtained from fetal rat circulation. Bone 35:850–858. https://doi.org/10.1016/j.bone.2004.05.006
Navas A, Magaña-Guerrero FS, Domínguez-López A et al (2018) Anti-inflammatory and anti-fibrotic effects of human amniotic membrane mesenchymal stem cells and their potential in corneal repair. Stem Cells Transl Med 7:906–917. https://doi.org/10.1002/sctm.18-0042
Neirinckx V, Coste C, Rogister B, Wislet-Gendebien S (2013) Concise review: adult mesenchymal stem cells, adult neural crest stem cells, and therapy of neurological pathologies: a state of play. Stem Cells Transl Med 2:284–296. https://doi.org/10.5966/sctm.2012-0147
Palombella S, Perucca Orfei C, Castellini G et al (2022) Systematic review and meta-analysis on the use of human platelet lysate for mesenchymal stem cell cultures: comparison with fetal bovine serum and considerations on the production protocol. Stem Cell Res Ther 13:1–31. https://doi.org/10.1186/s13287-022-02815-1
Patel DK, Jin B, Dutta SD, Lim KT (2020) Osteogenic potential of human mesenchymal stem cells on eggshells-derived hydroxyapatite nanoparticles for tissue engineering. J Biomed Mater Res Part B Appl Biomater 108:1953–1960. https://doi.org/10.1002/jbm.b.34536
Päth G, Perakakis N, Mantzoros CS, Seufert J (2019) Stem cells in the treatment of diabetes mellitus—focus on mesenchymal stem cells. Metabolism 90:1–15. https://doi.org/10.1016/j.metabol.2018.10.005
Pesarini JR, de Oliveira EJT, Pessatto LR et al (2018) Calcitriol combined with calcium chloride causes apoptosis in undifferentiated adipose tissue-derived human mesenchymal stem cells, but this effect decreases during adipogenic differentiation. Biomed Pharmacother 108:914–924. https://doi.org/10.1016/j.biopha.2018.09.083
Poomani MS, Mariappan I, Perumal R et al (2022) Mesenchymal stem cell (MSCs) therapy for ischemic heart disease: a promising frontier. Glob Heart 17:1. https://doi.org/10.5334/gh.1098
Pourgholaminejad A, Aghdami N, Baharvand H, Moazzeni SM (2016) The effect of pro-inflammatory cytokines on immunophenotype, differentiation capacity and immunomodulatory functions of human mesenchymal stem cells. Cytokine 85:51–60. https://doi.org/10.1016/j.cyto.2016.06.003
Ratajczak MZ (2015) A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking. Leukemia 29:776–782. https://doi.org/10.1038/leu.2014.346
Samsonraj RM, Paradise CR, Dudakovic A et al (2018) Validation of osteogenic properties of cytochalasin D by high-resolution RNA-sequencing in mesenchymal stem cells derived from bone marrow and adipose tissues. Stem Cells Dev 27:1136–1145. https://doi.org/10.1089/scd.2018.0037
Satheesan L, Soundian E, Kumanan V, Kathaperumal K (2020) Potential of ovine Wharton jelly derived mesenchymal stem cells to transdifferentiate into neuronal phenotype for application in neuroregenerative therapy. Int J Neurosci 130:1101–1108. https://doi.org/10.1080/00207454.2020.1725510
Sheng G (2015) The developmental basis of mesenchymal stem/stromal cells (MSCs). BMC Dev Biol 15:26–31. https://doi.org/10.1186/s12861-015-0094-5
Shi Y, Wang Y, Li Q et al (2018) Immunoregulatory mechanisms of mesenchymal stem and stromal cells in inflammatory diseases. Nat Rev Nephrol 14:493–507. https://doi.org/10.1038/s41581-018-0023-5
Shih DTB, Burnouf T (2015) Preparation, quality criteria, and properties of human blood platelet lysate supplements for ex vivo stem cell expansion. New Biotechnol 32:199–211. https://doi.org/10.1016/j.nbt.2014.06.001
Shufaro Y, Reubinoff BE (2004) Therapeutic applications of embryonic stem cells. Best Pract Res Clin Obstet Gynaecol 18:909–927. https://doi.org/10.1016/j.bpobgyn.2004.07.002
Siegel G, Kluba T, Hermanutz-Klein U et al (2013) Phenotype, donor age and gender affect function of human bone marrow-derived mesenchymal stromal cells. BMC Med. https://doi.org/10.1186/1741-7015-11-146
Silva-Carvalho AÉ, Neves FAR, Saldanha-Araujo F (2020) The immunosuppressive mechanisms of mesenchymal stem cells are differentially regulated by platelet poor plasma and fetal bovine serum supplemented media. Int Immunopharmacol 79:106172. https://doi.org/10.1016/j.intimp.2019.106172
Souza CMCO, Mesquita LAF, Souza D et al (2014) Regeneration of skin tissue promoted by mesenchymal stem cells seeded in nanostructured membrane. Transplant Proc 46:1882–1886. https://doi.org/10.1016/j.transproceed.2014.05.066
Spitzhorn LS, Rahman MS, Schwindt L et al (2017) Isolation and molecular characterization of amniotic fluid-derived mesenchymal stem cells obtained from caesarean sections. Stem Cells Int. https://doi.org/10.1155/2017/5932706
Talele NP, Fradette J, Davies JE et al (2015) Expression of α-smooth muscle actin determines the fate of mesenchymal stromal cells. Stem Cell Rep 4:1016–1030. https://doi.org/10.1016/j.stemcr.2015.05.004
Tancharoen W, Aungsuchawan S, Pothacharoen P et al (2019) Human platelet lysate as an alternative to fetal bovine serum for culture and endothelial differentiation of human amniotic fluid mesenchymal stem cells. Mol Med Rep 19:5123–5132. https://doi.org/10.3892/mmr.2019.10182
Timaner M, Tsai KK, Shaked Y (2020) The multifaceted role of mesenchymal stem cells in cancer. Semin Cancer Biol 60:225–237. https://doi.org/10.1016/j.semcancer.2019.06.003
Tong CK, Vellasamy S, Tan BC et al (2011) Generation of mesenchymal stem cell from human umbilical cord tissue using a combination enzymatic and mechanical disassociation method. Cell Biol Int 35:221–226. https://doi.org/10.1042/CBI20100326
Tsiklauri L, Werner J, Kampschulte M et al (2018) Visfatin alters the cytokine and matrix-degrading enzyme profile during osteogenic and adipogenic MSC differentiation. Osteoarthr Cartil 26:1225–1235. https://doi.org/10.1016/j.joca.2018.06.001
Ullah I, Subbarao RB, Rho GJ (2015) Human mesenchymal stem cells—current trends and future prospective. Biosci Rep. https://doi.org/10.1042/BSR20150025
Viau S, Chabrand L, Eap S et al (2016) Human platelet lysate pathogen reduced through additive-free short-wave UV light irradiation retains its optimal efficacy for the expansion of human bone marrow mesenchymal stem cells. Cytotherapy 18:S131–S132. https://doi.org/10.1016/j.jcyt.2016.03.255
Volkman R, Offen D (2017) Concise review: mesenchymal stem cells in neurodegenerative diseases. Stem Cells 35:1867–1880. https://doi.org/10.1002/stem.2651
Wosczyna MN, Konishi CT, Perez Carbajal EE et al (2019) Mesenchymal stromal cells are required for regeneration and homeostatic maintenance of skeletal muscle. Cell Rep 27:2029-2035.e5. https://doi.org/10.1016/j.celrep.2019.04.074
Yao P, Zhou L, Zhu L et al (2020) Mesenchymal stem cells: a potential therapeutic strategy for neurodegenerative diseases. Eur Neurol 83:235–241. https://doi.org/10.1159/000509268
Yue R, Zhou BO, Shimada IS et al (2016) Leptin receptor promotes adipogenesis and reduces osteogenesis by regulating mesenchymal stromal cells in adult bone marrow. Cell Stem Cell 18:782–796. https://doi.org/10.1016/j.stem.2016.02.015
Yun CW, Lee SH (2019) Enhancement of functionality and therapeutic efficacy of cell-based therapy using mesenchymal stem cells for cardiovascular disease. Int J Mol Sci. https://doi.org/10.3390/ijms20040982
Zachar L, Bačenková D, Rosocha J (2016) Activation, homing, and role of the mesenchymal stem cells in the inflammatory environment. J Inflamm Res 9:231–240. https://doi.org/10.2147/JIR.S121994
Zeng G, Wang G, Guan F et al (2011) Human amniotic membrane-derived mesenchymal stem cells labeled with superparamagnetic iron oxide nanoparticles: the effect on neuron-like differentiation in vitro. Mol Cell Biochem 357:331–341. https://doi.org/10.1007/s11010-011-0904-4
Zheng YH, Xiong W, Su K et al (2013) Multilineage differentiation of human bone marrow mesenchymal stem cells in vitro and in vivo. Exp Ther Med 5:1576–1580. https://doi.org/10.3892/etm.2013.1042
Zhou Z, Chen Y, Zhang H et al (2013) Comparison of mesenchymal stromal cells from human bone marrow and adipose tissue for the treatment of spinal cord injury. Cytotherapy 15:434–448. https://doi.org/10.1016/j.jcyt.2012.11.015
Acknowledgements
Not applicable.
Funding
No funding available.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Poomani, M.S., Regurajan, R., Perumal, R. et al. Differentiation of placenta-derived MSCs cultured in human platelet lysate: a xenofree supplement. 3 Biotech 14, 116 (2024). https://doi.org/10.1007/s13205-024-03966-z
Received:
Accepted:
Published:
DOI: https://doi.org/10.1007/s13205-024-03966-z